Innoviva Inc. (INVA) is a global holding company with a portfolio of royalties. Innoviva Inc. partners with companies that specialise in medicine development primarily for respiratory and cardiovascular diseases.
Operating within the biotechnology industry, Innoviva Inc. collaborates with partners such as Glaxo Group Limited (GSK) and other healthcare investments and assets to develop areas of unmet medical need. The company’s portfolio includes respiratory assets partnered with GSK for multiple respiratory disorders.
Monitor the INVA share price by adding it to your eToro watchlist.